Related Experiment Video
Updated: Aug 18, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
[Rectal carcinoma. Analysis of 10-year results]
1Chirurgische Klinik, Kreiskrankenhaus Detmold.
Abstract:
Between 1974 and 1979 139 patients with rectal cancer have been operated. Operative mortality was 14.4%. The fate of all patients was followed during 10 to 16 years. 46.8% of of patients died from recurrencies and metastases after a medium of 27.5 months. 3.6% died from another malignancy, 15.8% from other unrelated diseases. The 10-year survival rate is 22.3%; 19.4% of all patients are still alive with a mean survival time of 155 months. Prognosis depends mainly on tumour stage. No patient with recurrencies or metastases survived 10 years or longer.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025